Skip to content

Insider · CIK 0001835966

Alan B. Sandler

officerdirector

Files at RVMD (Revolution Medicines, Inc.), ELEV (Elevation Oncology, Inc.), ALXO (ALX ONCOLOGY HOLDINGS INC). First filing Sep 18, 2026, latest Oct 1, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.3M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RVMD: Revolution Medicines, Inc.

RVMDOct 9, 2026 · close 189.76

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
25Weak
RVMDsell 810b5-1
Revolution Medicines, Inc.
$1.3M
6,309 shares
-11%+347% from low-8% from high
18Weak
RVMDsell 910b5-1
Revolution Medicines, Inc.
$68k
341 shares
-1%+361% from low-11% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 29, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+6,000$58.84$353k58,86812 d ago
Sep 29, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,200$200.82$442k56,66812 d ago
Sep 29, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,609$201.72$325k55,05912 d ago
Sep 29, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,000$202.81$203k54,05912 d ago
Sep 29, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,199$203.91$244k52,86012 d ago
Sep 29, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-301$204.72$62k52,55912 d ago
Sep 29, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-6,000$0.00$0161,30012 d ago
Sep 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-5$194.96$97553,20425 d ago
Sep 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-336$199.30$67k52,86825 d ago
Jan 20, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AGrant or award
Stock option (right to buy)derivative
+10,100$0.00$010,100Jan 21, 2026
Jul 23, 2025ELEV
Elevation Oncology, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-55,000$0.00$00Jul 24, 2025
Jul 23, 2025ELEV
Elevation Oncology, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-35,000$0.00$00Jul 24, 2025
Jul 23, 2025ELEV
Elevation Oncology, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-35,000$0.00$00Jul 24, 2025
Jun 5, 2025ELEV
Elevation Oncology, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+35,000$0.00$035,000Jun 9, 2025
Apr 11, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AGrant or award
Employee Stock Option (right to buy)derivative
+125,000$0.00$0125,000Apr 15, 2025
Jan 21, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AGrant or award
Employee Stock Option (right to buy)derivative
+100,000$0.00$0100,000Jan 23, 2025
Nov 18, 2024ALXO
ALX ONCOLOGY HOLDINGS INC
AGrant or award
Employee Stock Option (right to buy)derivative
+600,000$0.00$0600,000Nov 19, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.